Literature DB >> 29228075

Errors in Text.

.   

Abstract

Year:  2018        PMID: 29228075      PMCID: PMC6325962          DOI: 10.1001/jamaneurol.2017.3996

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  1 in total

1.  Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

Authors:  Vladimir Skljarevski; Tina M Oakes; Qi Zhang; Margaret B Ferguson; James Martinez; Angelo Camporeale; Kirk W Johnson; Qiuling Shan; Jeffrey Carter; Aaron Schacht; Peter J Goadsby; David W Dodick
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.